[Vitrectomy combined with phacoemulsification and intraocular lens implantation for treatment of proliferative diabetic retinopathy].
OBJECTIVE
To determine clinical outcomes of vitrectomy and silicone oil tamponade combined with phacoemulsification and foldable intraocular lens (IOL) implantation for the treatment of severe proliferative diabetic retinopathy (PDR).


METHODS
Fifty-three patients (57 eyes) with proliferative diabetic retinopathy were included in this study. All patients had tractional or tractional-rhegmatogenous retinal detachment. These patients were divided into combined surgery group and vitrectomy group. Thirty-three patients (33 eyes) of combined surgery group underwent vitreoretinal surgery and silicone oil tamponade combined with phacoemulsification and foldable intraocular implantation. Twenty patients (24 eyes) of vitrectomy group underwent vitreoretinal surgery and silicone oil tamponade only. The postoperative rates of retinal reattachment and complications were analyzed.


RESULTS
Rates of retinal reattachment in combined surgery group was 87.9% vs. 83.3% for vitrectomy groups. The difference in rates of retinal reattachment was not statistically significant between these 2 groups (P > 0.05). Rates of visual acuity better than 0.1 in combined surgery group was 60.6% vs. 33.3% in vitrectomy group 6 month after operation. The difference in rates of postoperative iris neovascularization was not statistically significant between these 2 groups (P > 0.05).


CONCLUSIONS
Combined vitreoretinal surgery and phacoemulsification with intraocular lens implantation is safe and effective in treating severe proliferative diabetic retinopathy. Combined surgery may prevent a second operation for post vitrectomy cataract, allowing earlier visual rehabilitation.
Liu
Da-Chuan
DC
Department of Ophthalmology, Xuanwu Hospital, Capital University of Medical Sciences, Beijing, China. ldc99@sina.com
Wu
Hang
H
Guo
Li
L
D000328:Adult; D000368:Aged; D003930:Diabetic Retinopathy / Q000601:surgery*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D018918:Phacoemulsification; D016896:Treatment Outcome; D014821:Vitrectomy